External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Infectious Disease IDWeek 2024
Roche and Genentech at

IDWeek 2024

October 16 - October 19
Los Angeles, CA
idweek.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Oct 16 / Roche
Prototype Assay for Detection of Carbapenem-Resistant Acinetobacter baumannii Complex (CRABC)
This prototype assay exhibited a high percentage agreement for the detection of carbapenem-resistant Acinetobacter baumannii complex (CRABC) directly from bronchoalveolar lavage, sputum/endotracheal aspirate, and positive blood culture samples when compared to culture and nucleic acid amplification tests. A future assay based on this prototype could be evaluated in a clinical trial to establish its utility in facilitating timely and appropriate antibiotic selection for patients with hospital-acquired/ventilator-associated pneumonia or bacteremia caused by CRABC.
Infectious Disease Antimicrobial resistance IDW-2024
08:00 AM
Duration 75mins Los Angeles, CA
Prototype Assay for Detection of Carbapenem-Resistant Acinetobacter baumannii Complex (CRABC)
Brian P. Lee
Infectious Disease | Antimicrobial resistance

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.